Respiratory consequences of prematurity: Evolution of a diagnosis and development of a comprehensive approach

Journal of Perinatology

Volumn 35, Issue 5, 2015, Pages 313-321

  Maitre, N L ^a   Ballard, R A ^b   Ellenberg, J H ^c   Davis, S D ^d   Greenberg, J M ^e   Hamvas, A ^f,g   Pryhuber, G S ^h  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d INDIANA UNIVERSITY   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD CARE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY INTERVENTION; HUMAN; LUNG COMPLICATION; LUNG DYSPLASIA; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PREDICTION; PREMATURITY; QUANTITATIVE ANALYSIS; TIME TO TREATMENT; BRONCHOPULMONARY DYSPLASIA; GESTATIONAL AGE; NEONATAL INTENSIVE CARE UNIT; NEWBORN; RISK FACTOR;

BRONCHOPULMONARY DYSPLASIA; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; RISK FACTORS;

EID: 84929134505     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2015.19     Document Type: Article

References (66)

1. Martin JA, Hamilton BE, Ventura SJ, Osterman MJK, Mathews TJ. Births: final data for 2011. National Vital Statistics Reports. In: Services USDoHaH (eds). National Center of Health Statistics: Hyattsville, MD, 2013, pp 1-69
2. Vom Hove M, Prenzel F, Uhlig HH, Robel-Tillig E. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. J Pediatr 2014; 164(1): 40-45, e44
3. Halterman JS, Lynch KA, Conn KM, Hernandez TE, Perry TT, Stevens TP. Environmental exposures and respiratory morbidity among very low birth weight infants at 1 year of life. Arch Dis Child 2009; 94(1): 28-32
4. Peacock JL, Marston L, Marlow N, Calvert SA, Greenough A. Neonatal and infant outcome in boys and girls born very prematurely. Pediatr Res 2012; 71(3): 305-310
5. Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 2003; 23(6): 451-456
6. Lovering AT, Elliott JE, Laurie SS, Beasley KM, Gust CE, Mangum TS., et al. Ventilatory and sensory responses in adult survivors of preterm birth and bronchopulmonary dysplasia with reduced exercise capacity. Ann Am Thorac Soc 2014; 11(10): 1528-1537
7. Clemm HH, Vollsaeter M, Roksund OD, Eide GE, Markestad T, Halvorsen T. Exercise capacity after extremely preterm birth. Development from adolescence to adulthood. Ann Am Thorac Soc 2014; 11(4): 537-545
8. Greenough A, Limb E, Marston L, Marlow N, Calvert S, Peacock J. Risk factors for respiratory morbidity in infancy after very premature birth. Arch Dis Child Fetal Neonatal Ed 2005; 90(4): F320-F323
9. NHLBI. Division of Lung Diseases and Office of Prevention, Education and Control, Publication No. 98-4081, 1998
10. Underwood MA, Danielsen B, Gilbert WM. Cost, causes and rates of rehospitalization of preterm infants. J Perinatol 2007; 27: 614-619
11. Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006; 118(1): 108-113
12. Stroustrup A, Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993-2006. Pediatrics 2010; 126(2): 291-297
13. Northway WH Jr., Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276(7): 357-368
14. Tooley WH. Epidemiology of bronchopulmonary dysplasia. J Pediatr 1979; 95(5 Pt 2): 851-858
15. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82(4): 527-532
16. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999; 46(6): 641-643
17. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163(7): 1723-1729
18. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A., et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004; 114(5): 1305-1311
19. Natarajan G, Pappas A, Shankaran S, Kendrick DE, Das A, Higgins RD., et al. Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum Dev 2012; 88(7): 509-515
20. Ryan RM. A new look at bronchopulmonary dysplasia classification. J Perinatol 2006; 26(4): 207-209
21. Beam KS, Aliaga S, Ahlfeld SK, Cohen-Wolkowiez M, Smith PB, Laughon MM. A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. J Perinatol 2014; 34(9): 705-710
22. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA., et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116(6): 1353-1360
23. Lefkowitz W, Rosenberg SH. Bronchopulmonary dysplasia: pathway from disease to long-term outcome. J Perinatol 2008; 28(12): 837-840
24. Kaplan E, Bar-Yishay E, Prais D, Klinger G, Mei-Zahav M, Mussaffi H., et al. Encouraging pulmonary outcome for surviving, neurologically intact, extremely premature infants in the postsurfactant era. Chest 2012; 142(3): 725-733
25. Cazzato S, Ridolfi L, Bernardi F, Faldella G, Bertelli L. Lung function outcome at school age in very low birth weight children. Pediatr Pulmonol 2013; 48(8): 830-837
26. Landry JS, Chan T, Lands L, Menzies D. Long-term impact of bronchopulmonary dysplasia on pulmonary function. Can Respir J 2011; 18(5): 265-270
27. Drysdale SB, Alcazar M, Wilson T, Smith M, Zuckerman M, Lauinger IL., et al. Respiratory outcome of prematurely born infants following human rhinovirus A and C infections. Eur J Pediatr 2014; 173(7): 913-919
28. Drysdale SB, Lo J, Prendergast M, Alcazar M, Wilson T, Zuckerman M., et al. Lung function of preterm infants before and after viral infections. Eur J Pediatr 2014; 173(11): 1497-1504
29. Bhattacharya S, Go D, Krenitsky DL, Huyck HL, Solleti SK, Lunger VA., et al. Genomewide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2012; 186(4): 349-358
30. O'Reilly M, Harding R, Sozo F. Altered small airways in aged mice following neonatal exposure to hyperoxic gas. Neonatology 2014; 105(1): 39-45
31. Albertine KH. Progress in understanding the pathogenesis of BPD using the baboon and sheep models. Semin Perinatol 2013; 37(2): 60-68
32. Collins JJ, Kunzmann S, Kuypers E, Kemp MW, Speer CP, Newnham JP., et al. Antenatal glucocorticoids counteract LPS changes in TGF-beta pathway and caveolin-1 in ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 2013; 304(6): L438-L444
33. Maniscalco WM, Watkins RH, Roper JM, Staversky R, O'Reilly MA. Hyperoxic ventilated premature baboons have increased p53, oxidant DNA damage and decreased VEGF expression. Pediatr Res 2005; 58(3): 549-556
34. Backstrom E, Hogmalm A, Lappalainen U, Bry K. Developmental stage is a major determinant of lung injury in a murine model of bronchopulmonary dysplasia. Pediatr Res 2011; 69(4): 312-318
35. Choo-Wing R, Syed MA, Harijith A, Bowen B, Pryhuber G, Janer C., et al. Hyperoxia and interferon-gamma-induced injury in developing lungs occur via cyclooxygenase-2 and the endoplasmic reticulum stress-dependent pathway. Am J Respir Cell Mol Biol 2013; 48(6): 749-757
36. Madurga A, Mizikova I, Ruiz-Camp J, Morty RE. Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2013; 305(12): L893-L905
37. Hilgendorff A, Reiss I, Ehrhardt H, Eickelberg O, Alvira CM. Chronic lung disease in the preterm infant. Lessons learned from animal models. Am J Respir Cell Mol Biol 2014; 50(2): 233-245
38. O'Reilly MA, Marr SH, Yee M, McGrath-Morrow SA, Lawrence BP. Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. Am J Respir Crit Care Med 2008; 177(10): 1103-1110
39. Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008; 93(6): F455-F461
40. Ambalavanan N, Carlo WA, D'Angio CT, McDonald SA, Das A, Schendel D., et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009; 123(4): 1132-1141
41. Schneibel KR, Fitzpatrick AM, Ping XD, Brown LA, Gauthier TW. Inflammatory mediator patterns in tracheal aspirate and their association with bronchopulmonary dysplasia in very low birth weight neonates. J Perinatol 2013; 33(5): 383-387
42. Speer CP. Pulmonary inflammation and bronchopulmonary dysplasia. J Perinatol 2006; 26(Suppl 1): S57-S62
43. Bhandari A, Bhandari V. Biomarkers in bronchopulmonary dysplasia. Paediatr Respir Rev 2013; 14(3): 173-179
44. Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009; 123(6): 1562-1573
45. Drysdale SB, Prendergast M, Alcazar M, Wilson T, Smith M, Zuckerman M., et al. Genetic predisposition of RSV infection-related respiratory morbidity in preterm infants. Eur J Pediatr 2014; 173(7): 905-912
46. Hadchouel A, Franco-Montoya ML, Delacourt C. Altered lung development in bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 2014; 100(3): 158-167
47. Schmolzer GM, Kumar M, Pichler G, Aziz K, O'Reilly M, Cheung PY. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ 2013; 347: f5980
48. Bhandari V. The potential of non-invasive ventilation to decrease BPD. Semin Perinatol 2013; 37(2): 108-114
49. Carroll JL, Agarwal A. Development of ventilatory control in infants. Paediatr Respir Rev 2010; 11(4): 199-207
50. Bates ML, Pillers DA, Palta M, Farrell ET, Eldridge MW. Ventilatory control in infants, children, and adults with bronchopulmonary dysplasia. Respir Physiol Neurobiol 2013; 189(2): 329-337
51. Kim DH, Kim HS, Choi CW, Kim EK, Kim BI, Choi JH. Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology 2012; 101(1): 40-46
52. Rhein LM, Dobson NR, Darnall RA, Corwin MJ, Heeren TC, Poets CF., et al. Effects of caffeine on intermittent hypoxia in infants born prematurely: a randomized clinical trial. JAMA Pediatr 2014; 168(3): 250-257
53. Heldt GP. Development of stability of the respiratory system in preterm infants. J Appl Physiol (1985) 1988; 65(1): 441-444
54. Davis PG, Thorpe K, Roberts R, Schmidt B, Doyle LW, Kirpalani H., et al. Evaluating Old Definitions for the New Bronchopulmonary Dysplasia. J Pediatr 2002; 140(5): 555-560
55. Hjalmarson O, Brynjarsson H, Nilsson S, Sandberg KL. Persisting hypoxaemia is an insufficient measure of adverse lung function in very immature infants. Arch Dis Child Fetal Neonatal Ed 2014; 99: F257-F262
56. Bhandari A, Panitch HB. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 2006; 30(4): 219-226
57. Robin B, Kim YJ, Huth J, Klocksieben J, Torres M, Tepper RS., et al. Pulmonary function in bronchopulmonary dysplasia. Pediatr Pulmonol 2004; 37(3): 236-242
58. Sanchez-Solis M, Garcia-Marcos L, Bosch-Gimenez V, Perez-Fernandez V, Pastor-Vivero MD, Mondejar-Lopez P. Lung function among infants born preterm, with or without bronchopulmonary dysplasia. Pediatr Pulmonol 2012; 47(7): 674-681
59. Friedrich L, Pitrez PM, Stein RT, Goldani M, Tepper R, Jones MH. Growth rate of lung function in healthy preterm infants. Am J Respir Crit Care Med 2007; 176(12): 1269-1273
60. Been JV, Lugtenberg MJ, Smets E, van Schayck CP, Kramer BW, Mommers M., et al. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. PLoS Med 2014; 11(1): e1001596
61. Schuh S, Coates AL, Binnie R, Allin T, Goia C, Corey M., et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr 2002; 140(1): 27-32
62. Hoo AF, Dezateux C, Henschen M, Costeloe K, Stocks J. Development of airway function in infancy after preterm delivery. J Pediatr 2002; 141(5): 652-658
63. Friedrich L, Stein RT, Pitrez PM, Corso AL, Jones MH. Reduced lung function in healthy preterm infants in the first months of life. Am J Respir Crit Care Med 2006; 173(4): 442-447
64. American Thoracic SEuropean Respiratory S. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med 2005; 172(11): 1463-1471
65. Broughton S, Sylvester KP, Fox G, Zuckerman M, Smith M, Milner AD., et al. Lung function in prematurely born infants after viral lower respiratory tract infections. Pediatr Infect Dis J 2007; 26(11): 1019-1024
66. Davis SD, Rosenfeld M, Kerby GS, Brumback L, Kloster MH, Acton JD., et al. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med 2010; 182(11): 1387-1397